Membrane Disrupting Lytic Peptide Conjugates Destroy Hormone Dependent and Independent Breast Cancer Cells in vitro and in vivo
- 1 March 2003
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 78 (1), 17-27
- https://doi.org/10.1023/a:1022169525521
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Tamoxifen to raloxifene and beyondSeminars in Oncology, 2001
- Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptorsThe Prostate, 2001
- Rethinking breast cancer risk and the environment: the case for the precautionary principle.Environmental Health Perspectives, 1998
- Presence of Functional Luteinizing Hormone/Chorionic Gonadotropin (hCG) Receptors in Human Breast Cell Lines: Implications Supporting the Premise that hCG Protects Women against Breast CancerBiology of Reproduction, 1997
- Human prostate tumor angiogenesis in nude mice: Metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cellsThe Anatomical Record, 1997
- Expression of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Gene in Benign Prostatic Hyperplasia and in Prostate Carcinoma in HumansBiology of Reproduction, 1997
- LHRH-receptors and LHRH-agonist treatment in ovarian cancer: An overviewThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Hormonal Regulation of Luteinizing Hormone/Chorionic Gonadotropin Receptor mRNA in Rat Ovarian Cells during Follicular Development and LuteinizationMolecular Endocrinology, 1990
- A randomized comparative trial of adriamycin versus methotrexate in combination drug therapyCancer, 1978
- Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancerCancer, 1975